Quick Answer
Cartesian Therapeutics, Inc. reported Shares Outstanding of 26.01 million shares for fiscal year 2025.
Cartesian Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 26.01M | +0.9% |
| 2024 | 25.77M | +377.4% |
| 2023 | 5.40M | -96.5% |
| 2022 | 153.04M | +23.8% |
| 2021 | 123.62M | +14.4% |
| 2020 | 108.07M | +25.2% |
| 2019 | 86.33M | +284.2% |
| 2018 | 22.47M | +0.6% |
| 2017 | 22.34M | +21.2% |
| 2016 | 18.44M | +748.4% |
| 2015 | 2.17M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 26.00M | +8.8% | +0.0% |
| June 30, 2025 | 26.00M | +45.9% | +0.2% |
| March 31, 2025 | 25.94M | +370.2% | +0.7% |
| December 31, 2024 | 25.77M | +377.4% | +7.8% |
| September 30, 2024 | 23.90M | -84.6% | +34.1% |
| June 30, 2024 | 17.82M | -88.4% | +223.0% |
| March 31, 2024 | 5.52M | -96.4% | +2.2% |
| December 31, 2023 | 5.40M | -96.5% | -96.5% |
- Cartesian Therapeutics, Inc. showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Cartesian Therapeutics, Inc.’s shares outstanding has grown by 1096.8% (from 2.17 million shares to 26.01 million shares).
- The most recent figure is from Cartesian Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: